Influence of a dopamine pathway additive genetic efficacy score on smoking cessation: results from two randomized clinical trials of bupropion-Reference-Cited by-同舟云学术

Influence of a dopamine pathway additive genetic efficacy score on smoking cessation: results from two randomized clinical trials of bupropion

Published:2013-09-18 Issue:12 Volume:108 Page:2202-2211
ISSN:0965-2140
Container-title:Addiction
language:en
Short-container-title:Addiction

Author:

David Sean P.¹²³,Strong David R.⁴,Leventhal Adam M.⁵,Lancaster Molly A.⁵,McGeary John E.⁶,Munafò Marcus R.⁷,Bergen Andrew W.²,Swan Gary E.²,Benowitz Neal L.⁸,Tyndale Rachel F.⁹,Conti David V.⁵,Brown Richard A.¹⁰,Lerman Caryn¹¹,Niaura Raymond¹⁰¹²

Affiliation:

1. Stanford University School of Medicine; Center for Education and Research in Family and Community Medicine; Division of General Medical Disciplines; Department of Medicine; Stanford CA USA

2. SRI International; Center for Health Sciences; Menlo Park CA USA

3. Alpert Medical School of Brown University; Department of Family Medicine; Pawtucket RI USA

4. University of California, San Diego; Division of Behavioral Medicine; Department of Family and Preventive Medicine; La Jolla CA USA

5. Keck School of Medicine of University of Southern California; Department of Preventive Medicine; Los Angeles CA USA

6. Providence VA Medical Center; Providence RI USA

7. University of Bristol; Department of Experimental Psychology; Bristol UK

8. University of California, San Francisco (UCSF); Division of Clinical Pharmacology; Departments of Medicine and Bioengineering and Therapeutic Sciences; San Francisco CA USA

9. University of Toronto; Departments of Psychiatry, Pharmacology and Toxicology; Centre for Addiction and Mental Health; Toronto ON Canada

10. Alpert Medical School of Brown University; Department of Psychiatry and Human Behavior; Providence RI USA

11. Perelman School of Medicine; University of Pennsylvania; Department of Psychiatry; Philadelphia PA USA

12. American Legacy Foundation; Schroeder Center for Tobacco and Policy Studies; Johns Hopkins Bloomberg School of Public Health; Department of Health, Behavior and Society; Baltimore MD USA

Publisher

Wiley

Subject

Psychiatry and Mental health,Medicine (miscellaneous)

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/add.12325/fullpdf

Reference63 articles.

1. 21st-century hazards of smoking and benefits of cessation in the United States;Jha;N Engl J Med,2013

2. Antidepressants for smoking cessation;Hughes;Cochrane Database Syst Rev,2007

3. Nicotine receptor partial agonists for smoking cessation;Cahill;Cochrane Database Syst Rev,2012

4. Nicotine replacement therapy for smoking cessation;Stead;Cochrane Database Syst Rev,2012

5. Behavioural interventions as adjuncts to pharmacotherapy for smoking cessation;Stead;Cochrane Database Syst Rev,2012

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The association of genetic polymorphisms within the dopaminergic system with nicotine dependence: A narrative review;Heliyon;2024-06

2. Single Nucleotide Polymorphisms Within DRD2, COMT, and DBH and Smoking Cessation: A Systematic Review Considering Genetic Differences by Ancestry and Biological Sex;Current Addiction Reports;2024-05-23

3. A randomized trial of the effects of COMT inhibition on subjective response to alcohol: Moderation by baseline COMT activity and mediation of alcohol self‐administration;Alcohol: Clinical and Experimental Research;2023-11-21

4. A scoping review of smoking cessation pharmacogenetic studies to advance future research across racial, ethnic, and ancestral populations;Frontiers in Genetics;2023-06-08

5. Antidepressants for smoking cessation;Cochrane Database of Systematic Reviews;2023-05-24